DK0699198T3 - N-benzoylmethyl-substituerede paroxetinderivater - Google Patents

N-benzoylmethyl-substituerede paroxetinderivater

Info

Publication number
DK0699198T3
DK0699198T3 DK95928869T DK95928869T DK0699198T3 DK 0699198 T3 DK0699198 T3 DK 0699198T3 DK 95928869 T DK95928869 T DK 95928869T DK 95928869 T DK95928869 T DK 95928869T DK 0699198 T3 DK0699198 T3 DK 0699198T3
Authority
DK
Denmark
Prior art keywords
pct
benzoylmethyl
substituted
sec
date
Prior art date
Application number
DK95928869T
Other languages
Danish (da)
English (en)
Inventor
Rafael Foguet
Santiago Gubert
Aurelio Sacristan
Jose A Ortiz
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK0699198T3 publication Critical patent/DK0699198T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK95928869T 1994-03-18 1995-03-17 N-benzoylmethyl-substituerede paroxetinderivater DK0699198T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09400582A ES2102295B1 (es) 1994-03-18 1994-03-18 Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
PCT/EP1995/001007 WO1995025732A1 (en) 1994-03-18 1995-03-17 N-p-HALOBENZOYLMETHYL DERIVATIVES OF 4-(p-FLUOROPHENYL)-3-((3,4-METHYLENE-DIOXY)PHENOXY)METHYL)PIPERIDINE

Publications (1)

Publication Number Publication Date
DK0699198T3 true DK0699198T3 (da) 1999-11-22

Family

ID=8285616

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95928869T DK0699198T3 (da) 1994-03-18 1995-03-17 N-benzoylmethyl-substituerede paroxetinderivater

Country Status (19)

Country Link
US (1) US5665736A (fi)
EP (1) EP0699198B1 (fi)
JP (1) JP3213324B2 (fi)
KR (1) KR0182093B1 (fi)
AT (1) ATE181734T1 (fi)
AU (1) AU678320B2 (fi)
CA (1) CA2163253C (fi)
DE (1) DE69510510T2 (fi)
DK (1) DK0699198T3 (fi)
ES (1) ES2102295B1 (fi)
FI (1) FI108862B (fi)
GR (1) GR3031282T3 (fi)
IL (1) IL112763A (fi)
NO (1) NO308002B1 (fi)
NZ (1) NZ283130A (fi)
PH (1) PH31388A (fi)
TW (1) TW416956B (fi)
WO (1) WO1995025732A1 (fi)
ZA (1) ZA951963B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
EP1394160A1 (en) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Process for preparing crystalline paroxetin hydrochloride
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
AU7708998A (en) 1997-05-29 1998-12-30 Smithkline Beecham Corporation Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
EP1318988A2 (en) 2000-09-11 2003-06-18 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
FI108862B (fi) 2002-04-15
JP3213324B2 (ja) 2001-10-02
KR960702456A (ko) 1996-04-27
IL112763A0 (en) 1995-05-26
AU2109495A (en) 1995-10-09
NO954538D0 (no) 1995-11-10
NO954538L (no) 1995-11-10
EP0699198B1 (en) 1999-06-30
FI955387A0 (fi) 1995-11-08
CA2163253A1 (en) 1995-09-28
ATE181734T1 (de) 1999-07-15
CA2163253C (en) 2004-08-10
FI955387A (fi) 1995-11-08
US5665736A (en) 1997-09-09
JPH08510477A (ja) 1996-11-05
GR3031282T3 (en) 1999-12-31
WO1995025732A1 (en) 1995-09-28
KR0182093B1 (ko) 1999-05-01
NZ283130A (en) 1996-11-26
DE69510510T2 (de) 1999-11-18
EP0699198A1 (en) 1996-03-06
ES2102295A1 (es) 1997-07-16
NO308002B1 (no) 2000-07-03
TW416956B (en) 2001-01-01
ZA951963B (en) 1996-03-11
IL112763A (en) 1998-03-10
ES2102295B1 (es) 1998-04-01
AU678320B2 (en) 1997-05-22
PH31388A (en) 1998-10-29
DE69510510D1 (de) 1999-08-05

Similar Documents

Publication Publication Date Title
DK0696281T3 (da) Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
ATE181734T1 (de) N-benzoylmethylsubstituierte paroxetinderivate
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
FI955386A0 (fi) 4-p-fluoribentsoyyli-1-piperidinyyli-propoksi-kromen-4-onijohdannaiset, niiden valmistus ja käyttö psykoosin ja skitsofrenian hoidossa
NO970474D0 (no) N-substituerte azabicykloheptan-derivater egnet som neuroleptika
AU5125798A (en) Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
IL108290A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
NO306673B1 (no) Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse
DK0871611T3 (da) Hidtil ukendte glycylanilidderivater, deres fremstilling og deres terapeutiske anvendelse